THE ABLATIVE EFFECT OF QUARTER DOSE BACILLUS CALMETTE-GUERIN ON A PAPILLARY MARKER LESION OF THE BLADDER-Reference-Cited by-同舟云学术

THE ABLATIVE EFFECT OF QUARTER DOSE BACILLUS CALMETTE-GUERIN ON A PAPILLARY MARKER LESION OF THE BLADDER

Published:2001-02 Issue:2 Volume:165 Page:401-403
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

MACK DORIS¹,HÖLTL WOLFGANG¹,BASSI PIERFRANCESCO¹,BRAUSI MAURIZIO¹,FERRARI PAOLA¹,de BALINCOURT CHRISTINE¹,SYLVESTER RICHARD¹,

Affiliation:

1. From Salzburg and Vienna, Austria, Padova, Milano and Modena, Italy, and Brussels, Belgium

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference15 articles.

1. Factors affecting recurrence and progression in superficial bladder tumors;Kurth;Eur J Cancer,1995

2. Phase II trials in Ta, T1 bladder cancer. The marker tumour concept;van der Meijden;Br J Urol,1996

3. Marker tumour response to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours;van der Meijden;Eur Urol,1996

4. Chemoresection in Ta-T1 bladder cancer;Bono;Eur Urol,1996

5. Transurethral resection for superficial bladder cancer;Hall;Probl Urol,1992

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial;European Urology;2023-11

2. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non–muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study;European Urology Focus;2023-11

3. The Impact of Dose Reduction of Bacillus Calmette–Guerin on Oncological Outcomes and Toxicity in Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis;Bladder Cancer;2023-09-25

4. A Restaging Transurethral Resection of the Bladder Is Always Necessary for High-grade T1 Non–muscle-invasive Bladder Cancer: Con;European Urology Focus;2023-07

5. Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer;World Journal of Urology;2023-06-17